<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">J Infect</span><span class="iso-abbrev" title="iso-abbrev">J. Infect</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">The Journal of Infection</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">0163-4453</span><span class="issn-epub" tagx="issn" title="issn-epub">1532-2742</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">The British Infection Association. Published by Elsevier Ltd.</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7151357">7151357</a></span><span class="publisher-id" title="publisher-id">S0163-4453(20)30154-7</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1016/j.jinf.2020.03.027">10.1016/j.jinf.2020.03.027</a></span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Herd immunity â€" estimating the level required to halt the COVID-19 epidemics in affected countries</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kwok</span><span class="given-names" tagx="given-names" title="given-names">Kin On</span></span><span class="email" tagx="email" title="email">kkokwok@cuhk.edu.hk</span><a href="#aff0001">a</a><a href="#cor0001">â�Ž</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lai</span><span class="given-names" tagx="given-names" title="given-names">Florence</span></span><a href="#aff0002">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wei</span><span class="given-names" tagx="given-names" title="given-names">Wan In</span></span><a href="#aff0001">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">Samuel Yeung Shan</span></span><a href="#aff0001">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">Julian W.T.</span></span><span class="email" tagx="email" title="email">Julian.Tang@uhl-tr.nhs.uk</span><a href="#aff0003">c</a><a href="#cor0001">â�Ž</a></span><span class="citation_author_institution" id="aff0001">[a], </span><span class="citation_author_institution" id="aff0002">[b], </span><span class="citation_author_institution" id="aff0003">[c], </span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">â�Ž</span>Corresponding authors. <span class="email" tagx="email" title="email">kkokwok@cuhk.edu.hk</span><span class="email" tagx="email" title="email">Julian.Tang@uhl-tr.nhs.uk</span></div> </div><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2020-3-3</span></span><span class="pub-date-ppub" title="pub-date-ppub">ppub: <span>2020-6</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-3-3</span></span><span class="volume" tagx="volume" title="volume">80</span><span class="issue" tagx="issue" title="issue">6</span><span class="fpage" tagx="fpage" title="fpage">e32</span><span class="lpage" tagx="lpage" title="lpage">e33</span><span class="history" title="history"><span class="accepted" title="accepted">accepted: 2020-3-18</span></span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder" />, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</span></span></div> </div> </div> <div class="body" title="body"> <p content-type="salutation"><i>Dear Editor</i><b>,</b></p> <p id="para0002">Previous workers have attempted to predict the cumulative number of cases of Coronavirus Disease 2019 (COVID-19) in China.<a href="#bib0001"><sup>1</sup></a> However, since then, the epidemic has rapidly evolved into a pandemic affecting multiple countries worlwide.<a href="#bib0002"><sup>2</sup></a> There have been serious debates about how to react to the spread of this disease, particularly by European countries, such as Italy, Spain, Germany, France and the UK, e.g. from closing schools and universities to locking down entire cities and countries. An alternative strategy would be to allow the causal virus (SARS-CoV-2) to spread to increase the population herd immunity, but at the same time protecting the elderly and those with multiple comorbidities, who are the most vulnerable to this virus.<a href="#bib0003"><sup>3</sup></a></p> <p id="para0003">Before initiating either of these strategies, we need to estimate the <i>basic</i> reproductive number (R<sub>0</sub>), or the more â€˜real-lifeâ€™ <i>effective</i> reproductive number (R<sub>t</sub>) for a given population. R<sub>0</sub> is the number of secondary cases generated by the presence of one infected individual in an otherwise fully susceptible, well-mixed population. R<sub>t</sub> is a more practical real-life version of this, which uses real-life data (from diagnostic testing and/or clinical surveillance) to estimate the reproductive number for an ongoing epidemic.</p> <p id="para0004">For this anaylsis, we will estimate R<sub>t</sub>, and we can do this by applying the exponential growth method,<a href="#bib0004"><sup>4</sup></a> using data on the daily number of new COVID-19 cases, together with a recent estimate of the serial interval (meanâ€¯=â€¯4.7 days, standard deviationâ€¯=â€¯2.9 days),<a href="#bib0005"><sup>5</sup></a> at a 0.05 significance level, with the mathematical software R (v3.6.1.).</p> <p id="para0005">Using these values of R<sub>t</sub>, we can then calculate the minimum (â€˜criticalâ€™) level of population immunity, P<sub>crit</sub>, acquired via vaccination or naturally-induced (i.e. after recovery from COVID-19), to halt the spread of infection in that population, using the formula: P<sub>crit</sub>=Â 1-(1/R<sub>t</sub>). So, for example, if the value of R<sub>t</sub>Â =Â 3 then P<sub>crit</sub>=Â 0.67, i.e. at least two-thirds of the population need to be immune.<a href="#bib0006"><sup>6</sup></a></p> <p id="para0006">As of 13 March 2020, there were 32 countries outside China with over 100 COVID-19 cases.<a href="#bib0007"><sup>7</sup></a> The seven countries with the highest number of infections were: the United States (<i>n</i>â€¯=â€¯2294), France (<i>n</i>â€¯=â€¯3671), Germany (<i>n</i>â€¯=â€¯3675), Spain (<i>n</i>â€¯=â€¯5232), Korea (<i>n</i>â€¯=â€¯8086), Iran (<i>n</i>â€¯=â€¯11,364) and Italy (<i>n</i>â€¯=â€¯17,660). The number of confirmed cases in the other 25 countries were less than 1200 (<a href="#tbl0001">Table 1</a> ). <div class="table-wrap_UNKNOWN" position="float" id="tbl0001"><span class="label" tagx="label" title="label">Table 1</span> </div></p><p>Estimates of SARS-CoV-2 effective reproduction number (R<sub>t</sub>) of 32 study countries (as of 13 March 2020,<a href="#bib0007"><b><sup>7</sup></b></a>), and the minimum proportion (Pcrit, as% of population) needed to have recovered from COVID-19 with subsequent immunity, to halt the epidemic in that population.</p>  <div tag="alt-text">
Table 1</div> <table frame="hsides" rules="groups"> <thead> <tr> <th valign="top">Study countries</th> <th valign="top">Population infected by COVID-19</th> <th valign="top">Estimates of effective reproduction number (R<sub>t</sub>) (95% CI), (<i>n</i>â€¯=â€¯32)</th> <th valign="top">Minimum proportion (%) of total population required to recover from COVID-19 to confer immunity (P<sub>crit</sub>)</th> </tr> </thead> <tbody> <tr> <td valign="top"><b>R<sub>t</sub> &amp;gt;4</b></td> <td valign="top" /> <td valign="top" /> <td valign="top" /> </tr> <tr> <td valign="top">Bahrain</td> <td valign="top">210</td> <td valign="top">6.64 (5.20, 8.61)</td> <td valign="top">85.0</td> </tr> <tr> <td valign="top">Slovenia</td> <td valign="top">141</td> <td valign="top">6.38 (4.91, 8.38)</td> <td valign="top">84.3</td> </tr> <tr> <td valign="top">Qatar</td> <td valign="top">320</td> <td valign="top">5.38 (4.59, 6.34)</td> <td valign="top">81.4</td> </tr> <tr> <td valign="top">Spain</td> <td valign="top">5232</td> <td valign="top">5.17 (4.98, 5.37)</td> <td valign="top">80.7</td> </tr> <tr> <td valign="top">Denmark</td> <td valign="top">804</td> <td valign="top">5.08 (4.60, 5.62)</td> <td valign="top">80.3</td> </tr> <tr> <td valign="top">Finland</td> <td valign="top">155</td> <td valign="top">4.52 (3.72, 5.56)</td> <td valign="top">77.9</td> </tr> <tr> <td valign="top"><b>R<sub>t</sub> (2â€"4)</b></td> <td valign="top" /> <td valign="top" /> <td valign="top" /> </tr> <tr> <td valign="top">Austria</td> <td valign="top">504</td> <td valign="top">3.97 (3.56, 4.42)</td> <td valign="top">74.8</td> </tr> <tr> <td valign="top">Norway</td> <td valign="top">996</td> <td valign="top">3.74 (3.47, 4.04)</td> <td valign="top">73.3</td> </tr> <tr> <td valign="top">Portugal</td> <td valign="top">112</td> <td valign="top">3.68 (2.86, 4.75)</td> <td valign="top">72.8</td> </tr> <tr> <td valign="top">Czech Republic</td> <td valign="top">141</td> <td valign="top">3.57 (2.88, 4.45)</td> <td valign="top">72.0</td> </tr> <tr> <td valign="top">Sweden</td> <td valign="top">814</td> <td valign="top">3.44 (3.20, 3.71)</td> <td valign="top">70.9</td> </tr> <tr> <td valign="top">The United States</td> <td valign="top">2294</td> <td valign="top">3.29 (3.15, 3.43)</td> <td valign="top">69.6</td> </tr> <tr> <td valign="top">Germany</td> <td valign="top">3675</td> <td valign="top">3.29 (3.18, 3.40)</td> <td valign="top">69.6</td> </tr> <tr> <td valign="top">Switzerland</td> <td valign="top">1139</td> <td valign="top">3.26 (3.05, 4.78)</td> <td valign="top">69.3</td> </tr> <tr> <td valign="top">Brazil</td> <td valign="top">151</td> <td valign="top">3.26 (2.99, 3.55)</td> <td valign="top">69.3</td> </tr> <tr> <td valign="top">Netherlands</td> <td valign="top">804</td> <td valign="top">3.25 (3.02, 3.51)</td> <td valign="top">69.2</td> </tr> <tr> <td valign="top">Greece</td> <td valign="top">190</td> <td valign="top">3.12 (2.67, 3.67)</td> <td valign="top">67.9</td> </tr> <tr> <td valign="top">France</td> <td valign="top">3661</td> <td valign="top">3.09 (2.99, 3.19)</td> <td valign="top">67.6</td> </tr> <tr> <td valign="top">Israel</td> <td valign="top">143</td> <td valign="top">3.02 (2.56, 3.59)</td> <td valign="top">66.9</td> </tr> <tr> <td valign="top">The United Kingdom</td> <td valign="top">798</td> <td valign="top">2.90 (2.72, 3.10)</td> <td valign="top">65.5</td> </tr> <tr> <td valign="top">Italy</td> <td valign="top">17,660</td> <td valign="top">2.44 (2.41, 2.47)</td> <td valign="top">59.0</td> </tr> <tr> <td valign="top">Canada</td> <td valign="top">198</td> <td valign="top">2.30 (2.07, 2.57)</td> <td valign="top">56.5</td> </tr> <tr> <td valign="top">Iceland</td> <td valign="top">134</td> <td valign="top">2.28 (1.90, 2.75)</td> <td valign="top">56.1</td> </tr> <tr> <td valign="top"><b>R<sub>t</sub> (1â€"2)</b></td> <td valign="top" /> <td valign="top" /> <td valign="top" /> </tr> <tr> <td valign="top">Iran</td> <td valign="top">11,364</td> <td valign="top">2.00 (1.96, 2.03)</td> <td valign="top">50.0</td> </tr> <tr> <td valign="top">Australia</td> <td valign="top">199</td> <td valign="top">1.86 (1.71, 2.03)</td> <td valign="top">46.2</td> </tr> <tr> <td valign="top">Belgium</td> <td valign="top">559</td> <td valign="top">1.75 (1.55, 1.97)</td> <td valign="top">42.9</td> </tr> <tr> <td valign="top">Malaysia</td> <td valign="top">197</td> <td valign="top">1.74 (1.61, 1.88)</td> <td valign="top">42.5</td> </tr> <tr> <td valign="top">Iraq</td> <td valign="top">101</td> <td valign="top">1.67 (1.41,1.97)</td> <td valign="top">40.1</td> </tr> <tr> <td valign="top">Japan</td> <td valign="top">734</td> <td valign="top">1.49 (1.44, 1.54)</td> <td valign="top">32.9</td> </tr> <tr> <td valign="top">Korea</td> <td valign="top">8086</td> <td valign="top">1.43 (1.42, 1.45)</td> <td valign="top">30.1</td> </tr> <tr> <td valign="top">Singapore</td> <td valign="top">200</td> <td valign="top">1.13 (1.06, 1.19)</td> <td valign="top">11.5</td> </tr> <tr> <td valign="top">Kuwait</td> <td valign="top">100</td> <td valign="top">1.06 (0.89, 1.26)</td> <td valign="top">5.66</td> </tr> </tbody> </table>  <p /> <p id="para0007">Exploring these parameters and their implications further, the difference between R<sub>0</sub> and R<sub>t</sub> is related to the proportion of individuals that are already immune (either by vaccination or natural infection) to that pathogen in that population. So another way of calculating R<sub>t</sub> for a pathogen in a given population is by multiplying R<sub>0</sub> by the proportion of that population that is non-immune (i.e. susceptible) to that pathogen.<a href="#bib0006"><sup>6</sup></a> Hence, R<sub>0</sub> will only equal R<sub>t</sub> when there are no immune individuals in the population (i.e. when all are susceptible). This means that any partial, pre-existing immunity to the infecting agent can reduce the number of expected secondary cases arising.</p> <p id="para0008">Although SARS-CoV-2 is a new coronavirus, one source of possible partial immunity to is some possible antibody cross-reactivity and partial immunity from previous infections with the common seasonal coronaviruses (OC43, 229E, NL63, HKU1) that have been circulating in human populations for decades, as was noted for SARS-CoV.<a href="#bib0008"><sup>8</sup></a> This could also be the case for SARS-CoV-2 and might explain why some individuals (perhaps those who have recently recovered from a seasonal coronavirus infection) have milder or asymptomatic infections.<a href="#bib0009"><sup>9</sup></a></p> <p id="para0009">Finally, returning to the concept of enhancing herd immunity to control the COVID-19 epidemic, given that the case fatality rate (CFR) of COVID-19 can be anything between 0.25â€"3.0% of a country's population,<a href="#bib0010"><sup>10</sup></a> the estimated number of people who could potentially die from COVID-19, whilst the population reaches the P<sub>crit</sub> herd immunity level, may be difficult to accept.<a href="#bib0003"><sup>3</sup></a></p> </div> <div class="back" title="back"> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="bib0001" /><span class="label" tagx="label" title="label">1</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fu</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ying</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zeng</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Long</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Simulating and forecasting the cumulative confirmed cases of SARS-CoV-2 in China by Boltzmann function-based regression analyses</span><span class="source" tagx="source" title="source">J Infect</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jinf.2020.02.019">10.1016/j.jinf.2020.02.019</a></span><span class="comment">pii: S0163-4453(20)30098-0</span></span></li> <li tag="ref"><a name="bib0002" /><span class="label" tagx="label" title="label">2</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: <i>COVID-19 situation in the WHO European Region</i></span></span><span class="year" tagx="year" title="year">2020</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">World Health Organization</span></span></li> <li tag="ref"><a name="bib0003" /><span class="label" tagx="label" title="label">3</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Coronavirus: some scientists say UK virus strategy is `risking lives'. <a href="https://www.bbc.co.uk/news/science-environment-51892402">https://www.bbc.co.uk/news/science-environment-51892402</a>. Accessed 14 March2020.</span></li> <li tag="ref"><a name="bib0004" /><span class="label" tagx="label" title="label">4</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wallinga</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lipsitch</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">How generation intervals shape the relationship between growth rates and reproductive numbers</span><span class="source" tagx="source" title="source">Proc Biol Sci</span><span class="volume" tagx="volume" title="volume">274</span><span class="issue" tagx="issue" title="issue">1609</span><span class="year" tagx="year" title="year">2007</span><span class="fpage" tagx="fpage" title="fpage">599</span><span class="lpage" tagx="lpage" title="lpage">604</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17476782">17476782</a></span></span></li> <li tag="ref"><a name="bib0005" /><span class="label" tagx="label" title="label">5</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nishiura</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Linton</span><span class="given-names" tagx="given-names" title="given-names">N.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Akhmetzhanov</span><span class="given-names" tagx="given-names" title="given-names">A.R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Serial interval of novel coronavirus (COVID-19) infections</span><span class="source" tagx="source" title="source">Int J Infect Dis</span><span class="year" tagx="year" title="year">2020</span></span></li> <li tag="ref"><a name="bib0006" /><span class="label" tagx="label" title="label">6</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anderson</span><span class="given-names" tagx="given-names" title="given-names">R.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">May</span><span class="given-names" tagx="given-names" title="given-names">R.M.</span></span></span><span class="chapter-title" tagx="chapter-title" title="chapter-title">Infectious Diseases of Humans: Dynamics and Control</span><span class="year" tagx="year" title="year">1992</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Oxford Science Publications</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Oxford, UK</span><span class="fpage" tagx="fpage" title="fpage">768</span><span class="comment">ISBN-10: 019854040X. ISBN-13: 978-0198540403</span></span></li> <li tag="ref"><a name="bib0007" /><span class="label" tagx="label" title="label">7</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: ProMED-mail</span></span><span class="chapter-title" tagx="chapter-title" title="chapter-title">COVID-19 update (39): global, more countries, stability, mitigation impact</span><span class="year" tagx="year" title="year">2020</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">WHO</span><span class="comment">Archive No. 20200314.7088746</span></span></li> <li tag="ref"><a name="bib0008" /><span class="label" tagx="label" title="label">8</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meyer</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Drosten</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MÃ¼ller</span><span class="given-names" tagx="given-names" title="given-names">M.A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Serological assays for emerging coronaviruses: challenges and pitfalls</span><span class="source" tagx="source" title="source">Virus Res</span><span class="volume" tagx="volume" title="volume">194</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">175</span><span class="lpage" tagx="lpage" title="lpage">183</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.virusres.2014.03.018">10.1016/j.virusres.2014.03.018</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24670324">24670324</a></span></span></li> <li tag="ref"><a name="bib0009" /><span class="label" tagx="label" title="label">9</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing</span><span class="source" tagx="source" title="source">China. Sci China Life Sci</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s11427-020-1661-4">10.1007/s11427-020-1661-4</a></span><span class="comment">[Epub ahead of print]</span></span></li> <li tag="ref"><a name="bib0010" /><span class="label" tagx="label" title="label">10</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wilson</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kvalsvig</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barnard</span><span class="given-names" tagx="given-names" title="given-names">L.T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baker</span><span class="given-names" tagx="given-names" title="given-names">M.G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Case-Fatality risk estimates for COVID-19 calculated by using a lag time for fatality</span><span class="source" tagx="source" title="source">Emerg Infect Dis</span><span class="volume" tagx="volume" title="volume">26</span><span class="issue" tagx="issue" title="issue">6</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.3201/eid2606.200320">10.3201/eid2606.200320</a></span><span class="comment">[Epub ahead of print]</span></span></li> </ul> </div> </div>  </body></html>